Programme - The British Society for Rheumatology

Programme: 

Thursday 14 April 2011 

Programme 

Thu 14 April 2011 

“A good balance of 

presentations relevant 

to clinical practice whilst 

offering opportunities 

to expand scientific 

knowledge.” 

Delegate 2010

The future of patient 

choice in biologics 

Empress Suite, The Grand 

Thursday 14 April 

07.45–09.15 

This is an MSD symposium 

Please note breakfast will be served before the symposium 

Date of preparation: January 2011 01–12 SIM.11.GB.58111.J

44 Programme |Thursday 14 April 2011 

Thursday 14 April 2011 

Sessions | Clinical 1 | Clinical 2 | Research | Late breaking | BHPR | General 

07.15 – 07.45 Industry supported symposia catering 

07.45 – 09.15 Industry supported symposia 

07.45 Roche Chugai | Regency (Hilton Metropole) 

Rheumatology: are the planets aligning? 

Chair: Prof David G I Scott, Norfolk and Norwich University Hospital NHS Trust, Norwich 

Aim: To provide education on the changing NHS environment at national and local level and the 

impact on clinical practice and patient outcomes 

Outcome 1: Delegates will have gained a greater understanding of the political and clinical changes 

occurring within the NHS 

Outcome 2: Delegates will leave the session with a clear understanding of specific and realistic changes 

they can make to their Rheumatology Service to ensure it is optimally placed to meet the 

challenges of the evolving NHS 

Welcome and introduction | Prof David G I Scott, Norfolk and Norwich University Hospital NHS Trust, Norwich 

07:50 The value of big science | Prof Brian Cox, University of Manchester and CERN, Geneva 

08:05 Big Bang: the changing face of the NHS | Professor Paul Corrigan, Management Consultant, London 

08:20 Evolution: what will these changes mean at a local level? | Prof David Kerr, University of Oxford, Oxford 

08:35 Bringing the elements together: making it work for Rheumatology | Dr Andrew Östör, Addenbrooke’s 

Hospital, Cambridge 

08:55 Question and answer session 

09:10 Summary and close | Prof David G I Scott, Norfolk and Norwich University Hospital NHS Trust, Norwich 

07.45 MSD | Empress Suite (The Grand) 

The future of patient choice in biologics 

Aim: An informative discussion around patient choice and involvement and how this influences 

patient management. 

Outcome 1: Understanding how to offer patient choice when there is an increasing number of 

biologics available 

Outcome 2: Understanding the need for patient choice and benefits of current options 

Outcome 3: The White Paper and Patient Empowerment

Programme | Thursday 14 April 2011 45 


MSD | Empress Suite (The Grand) 

Moving towards joint decision-making: a recipe for success? | Dr Sam Moore, UCL, London 

Does the informed patient exist: how can we work with them to achieve optimum outcomes? 

Dr Ruth Slack, West Suffolk Hospital, Bury St Edmonds 

The White Paper and patient empowerment: at the heart of the NHS | Ms Kate Gadsby, Royal Derby 

Hospital, Derby 

09.15 – 10.45 Exhibition | Tea and Coffee | Poster viewing 

10.45 – 12.45 Current therapeutic options for systemic sclerosis | Empress Suite (The Grand) 

Chairs: Prof Chris Denton, UCL Medical School, London and Dr Maya Buch, University of Leeds, Leeds 

Aim: To highlight the advances that have arisen in assessment and treatment of pulmonary 

complications of systemic sclerosis (scleroderma) and indicate how intense 

immunosuppression and targeted biological therapies have potential as disease modifying 

treatments in this disease 

Outcome 1: An understanding of goal-directed therapy for pulmonary arterial hypertension in scleroderma 

Outcome 2: An appreciation of outcome prediction and treatment options for interstitial lung 

fibrosis in scleroderma: when to treat and when to observe 

Outcome 3: Balance the benefit and toxicity of immunosuppressive treatments and potential of targeted 

therapy: lessons from inflammatory arthritis 

10.45 Current challenges in scleroderma | Prof Chris Denton, UCL Medical School, London 

11.00 Assessment and treatment of lung fibrosis in scleroderma | Dr Rachel Hoyles, Oxford Radcliffe 

Hospitals, Oxford 

11.30 Challenge of goal-directed therapy for pulmonary hypertension in scleroderma 

Dr Gerry Coghlan, Royal Free Hospital, London 

12.00 Immunosuppressive strategies in systemic sclerosis: enough already? | Prof Jaap van Laar, 

Newcastle University, Newcastle Upon Tyne 

12.30 Panel discussion 

10.45 – 12.45 Advances in early inflammatory arthritis | Oxford (Hilton Metropole) 

Chairs: Prof Michael Ehrenstein, UCL, London and Prof Costantino Pitzalis, Barts and the London, London 

Aim: To learn about early rheumatoid arthritis, from pathogenesis to novel therapies 

Outcome 1: Understand the issues relating to establishing and running an early arthritis clinic 

Outcome 2: Gain knowledge on the environmental and genetic risk factors of RA 

Outcome 3: Gain insights on how pathobiology may contribute to diverse disease outcome and response 

to therapy and be informed on the latest thoughts about how best to treat early RA 

10.45 Genetic and environmental risk factors in early rheumatoid arthritis | Prof Lars Klareskog, 

Karolinska University Hospital in Solna, Stockholm, Sweden



Advances in early inflammatory arthritis | Oxford (Hilton Metropole) 

11.10 How to establish an early arthritis clinic: pitfalls and opportunities to improve patient care 

Dr Karim Raza, University of Birmingham, Birmingham 

11.40 Can pathobiology inform disease outcome and response to therapy? | Prof Costantino Pitzalis, 

Barts and the London, London 

12.05 Pre rheumatoid arthritis and early rheumatoid arthritis: what does it mean? | Prof Paul Tak, 

Academic Medical Center/University of Amsterdam, Amsterdam, The Netherlands 

12.30 Panel discussion 

10.45 – 12.45 ARMA late breaking session | ARS (interactive audience response system) | Regency (Hilton Metropole) 

Chair: Mr Roy Lilley, NHS Commentator 

Everything you wanted to know about commissioning; but were afraid to ask 

Want to know more about Commissioning - but afraid to ask? Well this is the session for you. 

ARMA will bring together a panel of experts who will talk you through what is involved, the pitfalls and the 

successes and link you up with others that are trying to understand how rheumatology can work in an integrated 

way with primary care to provide the care that patients and you want 

Panel: MrAsh Soni, PEC Chair, NHS Lambeth | Dr Alan Nye, Associate Medical Director NHS Direct, 

Associate Medical Director Pennine Care NHS Foundation Trust, Director Pennine MSK Partnership Ltd, 

Principal in General Practice | Dr Chris Deighton, Consultant Rheumatologist | Dr Alan Hakim, Consultant 

Physician and Rheumatologist, Director of Strategy and Business Improvement 

10.45 – 12.45 BHPR and Arthritis Research UK presentation of prizes | Albert (The Grand) 

Chair: Ms Lindsey Hawley, President BHPR 

10.45 Introduction from the panel | Ms Lindsey Hawley, President BHPR, Mr Keir Windsor, Education Manager Arthritis 

Research UK and Mrs Alisa Bosworth, Chief Executive National Rheumatoid Arthritis Society 

10.50 BHPR Student/recently qualified health professional prize winner 

Miss Serena Naidoo University of Brighton, Brighton 

I could cry, the amount of shoes I can't get into 

11.05 BHPR Clinical prize winner 

Dr Lisa Roberts Arthritis Research UK senior lecturer in physiotherapy, Southampton 

Case study 'Jim' 

11. 20 Chris Moran poster prize winner 

The Chris Moran poster prize is awarded to the author of one audit and one research poster at the conference 

11.25 BHPR/Arthritis Research UK silver medal research prize 

Mr Gordon Hendry University of Western Sydney, Sydney, Australia (Presented by Dr Deborah Turner, 

Glasgow Caledonian University, Glasgow) 

Clinical and ultrasound (US) examinations of foot disease in juvenile idiopathic arthritis (JIA): interobserver 

agreement between a paediatric rheumatologist, podiatrist and a sonographer



BHPR and Arthritis Research UK presentation of prizes | Albert (The Grand) 

11.40 Arthritis Research UK/PRCA podiatry silver medal prize 

Dr Vicki Cameron-Fiddes 

A study to investigate the effectiveness of a commonly prescribed off-the-shelf foot orthosis on foot health related 

quality of life (QOL) in patients with early diagnosed rheumatoid arthritis (RA) 

12.00 NRAS patients in focus 2011 

Mrs Kanta Kumar, Nurse Researcher, Immunity and Infection Rheumatology Department, University of 

Birmingham, Birmingham 

The development of an Asian language helpline for South Asian patients with rheumatological conditions 

in Birmingham 

12.45 – 14.15 Applying psychological interventions to the management of inflammatory arthritis and 

musculoskeletal pain | Dukes (Hilton Metropole) 

Chairs: Dr Claire Goodchild, Institute of Psychiatry, London and Dr Emma Dures, Bristol Royal Infirmary, Bristol 

Spaces are limited to 60 for this interactive workshop. Registration for this session will be open from 

09.15 on Thursday 14 April 2011 in the registration area 

Aim: To increase knowledge of cognitive behavioural therapy (CBT) and motivational interviewing 

(MI) as useful tools in symptom management 

Outcome 1: Delegates will have been introduced to CBT and MI and introduce basic skills 

Outcome 2: Delegates will have learned how to recognise and address the impact of negative thoughts 

Outcome 3: Delegates will have been learned about the different applications of therapy 

12.45 Applying cognitive behavioural therapy for insomnia for patients with chronic pain 

Dr Nicole Tang and Dr Claire Goodchild, Institute of Psychiatry, London 

12.55 Applying cognitive behavioural approaches in a group for the self management of RA fatigue 

Dr Nicholas Ambler, The Pain Management Centre, Bristol and Dr Emma Dures, Bristol Royal Infirmary, Bristol 

13.05 Using MI to identify and combat negative styles of thinking: exploring resistance | Dr Marianne Morris. 

University of the West of England, Bristol and Ms Elizabeth Hale, Russells Hall Hospital, Birmingham 

13.15 Delegates will form three groups and each group will rotate for 20 minutes discussion on the 

above applications. 

12.45 – 14.15 Exhibition | Lunch



12.45 – 14.00 BSR AGM | Empress Suite (The Grand) 

You are invited to the BSR Annual General Meeting 

Come along and receive progress reports from the President, 

the Journal Editor, the Heberden Librarian and other Honorary Officers 

about the business of the Society which will also include: 

• 2010 Annual Accounts and subscriptions for 2012 

• Changes to the Society’s Articles 

• BSR Elections Results 

The meeting will also include a thank you and farewell session for departing officers. 

Your participation is valued so we hope to see you all there. Lunch is also provided. 

14.15 – 15.45 Vasculitis: current issues | Oxford (Hilton Metropole) 

Chair: Dr Chetan Mukhytar, Norfolk and Norwich University Hospital, Norwich 

Aim: To provide practicing clinicians with a useful update on current clinical management and 

how new research may drive the management of the vasculitides in new directions 

Outcome 1: To better understand the aetiopathogenesis of the vasculitides 

Outcome 2: To better understand the investigation and diagnosis of PMR/GCA 

Outcome 3: To better understand the appropriate use of novel therapies in vasculitis 

14.15 Pathogenesis of vasculitis | Prof Cees Kallenberg, University Medical Center Groningen, 

Groningen, The Netherlands 

14.45 What is the evidence for novel immunosuppressants/B cell depletion in vasculitis? 

Dr Rachel Jones, University of Cambridge, Cambridge 

15.05 Diagnosis and assessment of large vessel vasculitis | Dr Raashid Luqmani, University of Oxford, 

Nuffield Orthopaedic Hospital, Oxford 

15.25 Treatment of PMR/GCA | Prof Bhaskar Dasgupta, Southend Hospital University Foundation 

NHS Trust, Westcliffe on Sea



14.15 – 15.45 The era of biologics for children and young people with rheumatological disease | Albert (The Grand) 

Chairs: Dr Michael Beresford, Royal Liverpool Children’s Hospital, Liverpool and 

Dr Jacqui Clinch, Royal National Hospital for Rheumatic Diseases, Bath 

Aim: To provide a state-of-the-art overview of the latest translational and therapeutic advances for 

children and young people with rheumatic disease 

Outcome 1: Provide information on the latest advances in evidence base and clinical use of biologics in 

children and young people 

Outcome 2: Understand the importance of translational research in determining the mechanism of disease 

and treatment response in children 

Outcome 3: Identify the significant challenges and importance of specific expertise in treating children and 

adolescents, and requirements for dealing appropriately with their transition and transfer needs 

14.15 Therapeutic advances in juvenile idiopathic arthritis | Dr Athimalaipet Ramanan, Bristol Royal 

Hospital for Children and Royal National Hospital for Rheumatic Diseases, Bath 

14.35 Understanding the mechanism of disease and response to therapy in childhood arthritis 

Prof Lucy Wedderburn, Institute of Child Health, University College London and Great Ormond 

Street Hospital, London 

14.55 The young adult with juvenile idiopathic arthritis and biologics | Prof Helen Foster, 

The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne 

15.15 Genetics and biologic use in inflammatory disease | Dr Paul Brogan, Great Ormond Street Hospital, London 

14.15 – 15.45 Clinical musculoskeletal research in the UK (Arthritis Research UK and BSR joint session) 

Empress suite (The Grand) 

Chairs: Dr Clive Kelly, Queen Elizabeth Hospital, Gateshead and Prof David Scott, UCL, London 

Aim: To discuss with delegates: the need for developing strategic networks 

and funding for clinical musculoskeletal research in the UK 

Outcome 1: To review all current activity ranging from experimental medicine to studies of health care 

delivery, illustrating contribution of different funders and other stakeholders such as NICE 

Outcome 2: To present the structure, design and functioning of the new proposed network for arthritis and 

related research in the UK 

Outcome 3: A detailed presentation of how to participate, what are the logistic issues and how to solve 

them and to provide panel answers to questions from the floor 

14.15 Current and future activity in rheumatology trials | Prof Alan Silman, Arthritis Research UK 

14.35 Building a UK clinical research network in rheumatology | Prof David L Scott, UCL, London 

14.55 What are the practical issues? | Prof Deborah Symmons, University of Manchester, Manchester 

15.35 Panel discussion



14.15 – 15.45 Patient and public involvement in musculoskeletal research | Regency (Hilton Metropole) 

Chairs: Ms Sue Gurden, Gwent NHS Trust, Newport and Ms Catherine Ball, Imperial College, London 

Aim: To provide participants with an overview of patient and public involvement (PPI) in 

musculoskeletal research 

Outcome 1: Delegates will be able to identify the role of PPI in musculoskeletal research and 

clinical practice 

Outcome 2: Examples will be provided of PPI activity (national and international) 

Outcome 3: Delegates will enhance their understanding of the implementation of PPI in research 

and clinical practice 

14.15 The national agenda | Dr Sarah Buckland, INVOLVE, Leeds 

14.30 Public priorities for joint pain research | Dr Claire Jinks, Arthritis Research UK Primary Care Centre, Keele 

14.55 A decade of patient involvement in OMERACT: what difference has it made? 

Prof John Kirwan, Bristol Royal Infirmary, Bristol and Mr Maarten de Wit, OMERACT 

15.20 Patient and public involvement in the work of Cochrane Musculoskeletal Group 

Dr Tamara Rader, University of Ottawa, Ottawa, Canada 

15.45 – 16.15 Exhibition | Tea and Coffee 

16.15 – 17.15 Heberden Round | Oxford ( Hilton Metropole) 

Chair: Prof David L Scott, BSR President 

Aspects of infection | Prof Hill Gaston, Professor of Rheumatology, Addenbrooke’s Hospital, Cambridge

Programme - The British Society for Rheumatology

Create successful ePaper yourself

Delete template?

Save as template?